{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:29:45Z","timestamp":1774542585197,"version":"3.50.1"},"reference-count":125,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease, associated with a late diagnosis and a five-year survival rate of 8%. Currently available treatments fall short in improving the survival and quality of life of PDAC patients. The only possible curative option is still the surgical resection of the tumor. Exosomes are extracellular vesicles secreted by cells that transport proteins, lipids, and nucleic acids to other cells, triggering phenotypic changes in the recipient cells. Tumor cells often secrete increased amounts of exosomes. Tumor exosomes are now accepted as important players in the remodeling of PDAC tumor stroma, particularly in the establishment of an immunosuppressive microenvironment. This has sparked the interest in their usefulness as mediators of immunomodulatory effects for the treatment of PDAC. In fact, exosomes are now under study to understand their potential as nanocarriers to stimulate an immune response against cancer. This review highlights the latest findings regarding the function of exosomes in tumor-driven immunomodulation, and the challenges and advantages associated with the use of these vesicles to potentiate immunotherapy in PDAC.<\/jats:p>","DOI":"10.3390\/ijms20030567","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T11:27:52Z","timestamp":1548761272000},"page":"567","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Exosomes and the Future of Immunotherapy in Pancreatic Cancer"],"prefix":"10.3390","volume":"20","author":[{"given":"Ines A.","family":"Batista","sequence":"first","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Portugal (i3S),  4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology &amp; Immunology of the University of Porto (IPATIMUP),  4200-135 Porto, Portugal"}]},{"given":"Sonia A.","family":"Melo","sequence":"additional","affiliation":[{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, Portugal (i3S),  4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology &amp; Immunology of the University of Porto (IPATIMUP),  4200-135 Porto, Portugal"},{"name":"Medical Faculty of the University of Porto (FMUP),  4200-319 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"ref_1","unstructured":"Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2018, October 08). Global Cancer Observatory. Lyon, France: International Agency for Research on Cancer. Available online: https:\/\/gco.Iarc.Fr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pan.2014.10.001","article-title":"Addressing the challenges of pancreatic cancer: Future directions for improving outcomes","volume":"15","author":"Hidalgo","year":"2015","journal-title":"Pancreatology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Huang, L., Jansen, L., Balavarca, Y., Babaei, M., van der Geest, L., Lemmens, V., Van Eycken, L., De Schutter, H., Johannesen, T.B., and Primic-\u017dakelj, M. (2018). Stratified survival of resected and overall pancreatic cancer patients in europe and the USA in the early twenty-first century: A large, international population-based study. BMC Med., 16.","DOI":"10.1186\/s12916-018-1120-9"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrclinonc.2015.53","article-title":"Pancreatic cancer: From state-of-the-art treatments to promising novel therapies","volume":"12","author":"Hidalgo","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrclinonc.2013.66","article-title":"Advanced-stage pancreatic cancer: Therapy options","volume":"10","author":"Werner","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11894-014-0397-x","article-title":"Surgical management of pancreatic neoplasms: What\u2019s new?","volume":"16","author":"Karachristos","year":"2014","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.25763","article-title":"Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma","volume":"117","author":"Artinyan","year":"2011","journal-title":"Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11160","DOI":"10.3748\/wjg.v20.i32.11160","article-title":"Complex role for the immune system in initiation and progression of pancreatic cancer","volume":"20","author":"Inman","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1093\/annonc\/mdx503","article-title":"Immunotherapy in pancreatic ductal adenocarcinoma: An emerging entity?","volume":"28","author":"Sahin","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1158\/2326-6066.CIR-14-0215","article-title":"Induction of t-cell immunity overcomes complete resistance to pd-1 and ctla-4 blockade and improves survival in pancreatic carcinoma","volume":"3","author":"Winograd","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent ipilimumab (anti-ctla-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/annonc\/mdu205","article-title":"A phase i dose escalation trial of tremelimumab (cp-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer","volume":"25","author":"Aglietta","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-pd-l1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: A common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5306\/wjco.v8.i3.230","article-title":"Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations","volume":"8","author":"Guo","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","article-title":"Exosomes: Composition, biogenesis and function","volume":"2","author":"Zitvogel","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by extracellular vesicles: Where we are and where we need to go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1101\/sqb.2016.81.030932","article-title":"Discovery of double-stranded genomic DNA in circulating exosomes","volume":"81","author":"Kalluri","year":"2016","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic kras in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Ostrowski","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4049\/jimmunol.1400703","article-title":"Dendritic cell-derived exosomes as immunotherapies in the fight against cancer","volume":"193","author":"Pitt","year":"2014","journal-title":"J. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0092-8674(83)90040-5","article-title":"Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor","volume":"33","author":"Pan","year":"1983","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fonc.2018.00066","article-title":"The origin and functions of exosomes in cancer","volume":"8","author":"Rajagopal","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: Biology and emerging therapeutic opportunities","volume":"12","author":"Breakefield","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/cr.2014.44","article-title":"Double-stranded DNA in exosomes: A novel biomarker in cancer detection","volume":"24","author":"Thakur","year":"2014","journal-title":"Cell. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/15384047.2017.1281499","article-title":"Detection of mutant kras and tp53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-015-0181-x","article-title":"Exosomes in cancer: Small particle, big player","volume":"8","author":"Zhang","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"Microrna signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/blood-2004-03-0824","article-title":"Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells","volume":"104","author":"Morelli","year":"2004","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4049\/jimmunol.179.3.1489","article-title":"Cd8+ dendritic cells use lfa-1 to capture mhc-peptide complexes from exosomes in vivo","volume":"179","author":"Segura","year":"2007","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2008-08-174094","article-title":"Activated t cells recruit exosomes secreted by dendritic cells via lfa-1","volume":"113","author":"Buschow","year":"2009","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.biocel.2012.06.018","article-title":"Toward tailored exosomes: The exosomal tetraspanin web contributes to target cell selection","volume":"44","author":"Rana","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcdb.2015.02.010","article-title":"Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes","volume":"40","author":"Minciacchi","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/19336918.2016.1250999","article-title":"Exosomes in cancer theranostic: Diamonds in the rough","volume":"11","author":"Cordonnier","year":"2017","journal-title":"Cell. Adh. Migr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ceb.2007.12.002","article-title":"Escrt complexes and the biogenesis of multivesicular bodies","volume":"20","author":"Hurley","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrm2162","article-title":"The emerging shape of the escrt machinery","volume":"8","author":"Williams","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bbrc.2010.07.083","article-title":"Exosome secretion of dendritic cells is regulated by hrs, an escrt-0 protein","volume":"399","author":"Tamai","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/ncb2574","article-title":"Active wnt proteins are secreted on exosomes","volume":"14","author":"Gross","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"ref_46","first-page":"5553","article-title":"Analysis of escrt functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J. Cell Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1600-0854.2009.00920.x","article-title":"Multivesicular endosome biogenesis in the absence of escrts","volume":"10","author":"Stuffers","year":"2009","journal-title":"Traffic"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.devcel.2011.08.019","article-title":"The tetraspanin cd63 regulates escrt-independent and -dependent endosomal sorting during melanogenesis","volume":"21","author":"Charrin","year":"2011","journal-title":"Dev. Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M112.445304","article-title":"The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes","volume":"288","author":"Jorge","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/0008-5472.CAN-09-2470","article-title":"Cell surface tetraspanin tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation","volume":"70","author":"Nazarenko","year":"2010","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0854.2004.0167.x","article-title":"Degradation of ap2 during reticulocyte maturation enhances binding of hsc70 and alix to a common site on tfr for sorting into exosomes","volume":"5","author":"Blanc","year":"2004","journal-title":"Traffic"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2017.08.009","article-title":"Exosomes in cancer: Use them or target them?","volume":"78","author":"Bastos","year":"2018","journal-title":"Semin. Cell. Dev. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1158\/0008-5472.CAN-17-0994","article-title":"The biology of cancer exosomes: Insights and new perspectives","volume":"77","author":"Ruivo","year":"2017","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","article-title":"Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells","volume":"65","author":"Gastpar","year":"2005","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","article-title":"Microrna expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis","volume":"297","author":"Bloomston","year":"2007","journal-title":"JAMA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2014.09.004","article-title":"Pancreatic cancer derived exosomes regulate the expression of tlr4 in dendritic cells via mir-203","volume":"292","author":"Zhou","year":"2014","journal-title":"Cell. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.18632\/oncotarget.4924","article-title":"Pancreatic cancer-derived exosomes transfer mirnas to dendritic cells and inhibit rfxap expression via mir-212-3p","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"84928","DOI":"10.18632\/oncotarget.20863","article-title":"Pdac-derived exosomes enrich the microenvironment in mdscs in a smad4-dependent manner through a new calcium related axis","volume":"8","author":"Basso","year":"2017","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/bjc.2013.32","article-title":"Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer","volume":"108","author":"Ino","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal pd-l1 contributes to immunosuppression and is associated with anti-pd-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-017-0269-7","article-title":"Tumor-derived exosomes induce cd8+ t cell suppressors","volume":"5","author":"Maybruck","year":"2017","journal-title":"J. Immunother. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1158\/0008-5472.CAN-13-3013","article-title":"Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and hedgehog signaling activation","volume":"74","author":"Moreno","year":"2014","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of m2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"J. Surg. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1007\/s13277-015-4741-z","article-title":"The m2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer","volume":"37","author":"Hu","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Linton, S.S., Abraham, T., Liao, J., Clawson, G.A., Butler, P.J., Fox, T., Kester, M., and Matters, G.L. (2018). Tumor-promoting effects of pancreatic cancer cell exosomes on thp-1-derived macrophages. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206759"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1158\/0008-5472.CAN-08-1060","article-title":"Prevention of both direct and cross-priming of antitumor cd8+ t-cell responses following overproduction of prostaglandin e2 by tumor cells in vivo","volume":"68","author":"Ahmadi","year":"2008","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4049\/jimmunol.175.3.1483","article-title":"Prostaglandin e2 induces foxp3 gene expression and t regulatory cell function in human cd4+ t cells","volume":"175","author":"Baratelli","year":"2005","journal-title":"J. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"55409","DOI":"10.18632\/oncotarget.10580","article-title":"Cd44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Aiello","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"63461","DOI":"10.18632\/oncotarget.18831","article-title":"Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_74","first-page":"457","article-title":"Membrane-associated hsp72 from tumor-derived exosomes mediates stat3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells","volume":"120","author":"Chalmin","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccell.2014.09.005","article-title":"Cancer exosomes perform cell-independent microrna biogenesis and promote tumorigenesis","volume":"26","author":"Melo","year":"2014","journal-title":"Cancer Cell."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/stem.1619","article-title":"Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes","volume":"32","author":"Yang","year":"2014","journal-title":"Stem Cells"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MPA.0000000000000722","article-title":"Exosomes derived from pancreatic stellate cells: Microrna signature and effects on pancreatic cancer cells","volume":"46","author":"Takikawa","year":"2017","journal-title":"Pancreas"},{"key":"ref_78","first-page":"15","article-title":"Exosomal lipids induce human pancreatic tumoral miapaca-2 cells resistance through the cxcr4-sdf-1\u03b1 signaling axis","volume":"2","author":"Siret","year":"2015","journal-title":"Oncoscience"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1073\/pnas.1220998110","article-title":"Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development","volume":"110","author":"Kucharzewska","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-18-0124","article-title":"Transfer of mirna in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma","volume":"78","author":"Binenbaum","year":"2018","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/jnci\/djq153","article-title":"Effect of the secretory small gtpase rab27b on breast cancer growth, invasion, and metastasis","volume":"102","author":"Hendrix","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/sj.onc.1207070","article-title":"The microvesicle as a vehicle for emmprin in tumor-stromal interactions","volume":"23","author":"Sidhu","year":"2004","journal-title":"Oncogene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/s41388-018-0237-9","article-title":"Tumor-derived exosomal lnc-sox2ot promotes emt and stemness by acting as a cerna in pancreatic ductal adenocarcinoma","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Blackwell, R.H., Foreman, K.E., and Gupta, G.N. (2017). The role of cancer-derived exosomes in tumorigenicity & epithelial-to-mesenchymal transition. Cancers (Basel), 9.","DOI":"10.3390\/cancers9080105"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1038\/s41598-017-05541-4","article-title":"Exosomes derived from pancreatic cancer cells induce insulin resistance in c2c12 myotube cells through the PI3K\/akt\/foxo1 pathway","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nbt.1830","article-title":"Sirna delivery with exosome nanoparticles","volume":"29","author":"Schlee","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of sirna to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Seow","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2015.03.021","article-title":"Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases","volume":"160","author":"Tran","year":"2015","journal-title":"Clin. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08982100902792855","article-title":"Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions","volume":"19","author":"Szebeni","year":"2009","journal-title":"J. Liposome Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/immu.200310028","article-title":"Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of cd55 and cd59","volume":"33","author":"Clayton","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","article-title":"A novel nanoparticle drug delivery system: The anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes","volume":"18","author":"Sun","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.canlet.2015.10.020","article-title":"Bovine milk-derived exosomes for drug delivery","volume":"371","author":"Munagala","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Cheng, L., Sharples, R.A., Scicluna, B.J., and Hill, A.F. (2014). Exosomes provide a protective and enriched source of mirna for biomarker profiling compared to intracellular and cell-free blood. J. Extracell. Vesicles, 3.","DOI":"10.3402\/jev.v3.23743"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12195-016-0458-3","article-title":"Elucidation of exosome migration across the blood-brain barrier model in vitro","volume":"9","author":"Chen","year":"2016","journal-title":"Cell. Mol. Bioeng."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1007\/s11095-014-1593-y","article-title":"Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in danio rerio","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7150\/thno.17092","article-title":"Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth","volume":"7","author":"Bellavia","year":"2017","journal-title":"Theranostics"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1021\/acsnano.5b06939","article-title":"Blood exosomes endowed with magnetic and targeting properties for cancer therapy","volume":"10","author":"Qi","year":"2016","journal-title":"ACS Nano"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mrnas and micrornas is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cell.2014.09.051","article-title":"Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways","volume":"159","author":"Boelens","year":"2014","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"96035","DOI":"10.18632\/oncotarget.21635","article-title":"Tgf\u03b21 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","article-title":"Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through tgf\u03b2 signaling","volume":"16","author":"Bernard","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/oncotarget.2711","article-title":"Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts","volume":"6","author":"Chowdhury","year":"2015","journal-title":"Oncotarget"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Aspe, J.R., Diaz Osterman, C.J., Jutzy, J.M., Deshields, S., Whang, S., and Wall, N.R. (2014). Enhancement of gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the survivin-t34a mutant. J. Extracell. Vesicles, 3.","DOI":"10.3402\/jev.v3.23244"},{"key":"ref_108","first-page":"440","article-title":"Exosome\/staphylococcal enterotoxin b, an anti tumor compound against pancreatic cancer","volume":"19","author":"Soleimanirad","year":"2014","journal-title":"J. BUON"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1093\/nar\/gks463","article-title":"Plasma exosomes can deliver exogenous short interfering rna to monocytes and lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm0598-594","article-title":"Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes","volume":"4","author":"Zitvogel","year":"1998","journal-title":"Nat. Med."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Viaud, S., Terme, M., Flament, C., Taieb, J., Andr\u00e9, F., Novault, S., Escudier, B., Robert, C., Caillat-Zucman, S., and Tursz, T. (2009). Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: A role for nkg2d ligands and il-15ralpha. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004942"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e1071008","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in nsclc","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/mt.2008.1","article-title":"Phase i clinical trial of autologous ascites-derived exosomes combined with gm-csf for colorectal cancer","volume":"16","author":"Dai","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"20254","DOI":"10.1038\/srep20254","article-title":"Tumor-derived exosomes regulate expression of immune function-related genes in human t cell subsets","volume":"6","author":"Muller","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Szajnik, M., Czystowska, M., Szczepanski, M.J., Mandapathil, M., and Whiteside, T.L. (2010). Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory t cells (treg). PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011469"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e1319044","DOI":"10.1080\/2162402X.2017.1319044","article-title":"Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer","volume":"6","author":"Xiao","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"30110","DOI":"10.1038\/srep30110","article-title":"Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of micrornas 155 and 125b2 transfection using nanoparticle delivery systems","volume":"6","author":"Su","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1158\/0008-5472.CAN-12-0925","article-title":"Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression","volume":"72","author":"Bobrie","year":"2012","journal-title":"Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1158\/0008-5472.CAN-13-3512","article-title":"Cellular disposal of mir23b by rab27-dependent exosome release is linked to acquisition of metastatic properties","volume":"74","author":"Ostenfeld","year":"2014","journal-title":"Cancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1038\/s41598-018-26411-7","article-title":"High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer","volume":"8","author":"Datta","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: Current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/medicines2040310","article-title":"Exosomes: Potential in cancer diagnosis and therapy","volume":"2","author":"Munson","year":"2015","journal-title":"Medicines"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome mdr in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4049\/jimmunol.172.4.2126","article-title":"Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional mhc class i\/peptide complexes to dendritic cells","volume":"172","author":"Chaput","year":"2004","journal-title":"J. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/3\/567\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:29:20Z","timestamp":1760185760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/3\/567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":125,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2]]}},"alternative-id":["ijms20030567"],"URL":"https:\/\/doi.org\/10.3390\/ijms20030567","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]}}}